BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2799766)

  • 1. Desmopressin induces decrease in platelet serotonin content in uremia.
    Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
    Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
    [No Abstract]   [Full Text] [Related]  

  • 2. A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
    Pietraszek M; Azzadin A; Buczko W; Malyszko J; Mysliwiec M
    Thromb Haemost; 1992 Nov; 68(5):625. PubMed ID: 1455414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
    Małyszko J; Małyszko J; Pietraszek M; Azzadin A; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1993 Aug; 90(2):105-11. PubMed ID: 8247943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
    Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076
    [No Abstract]   [Full Text] [Related]  

  • 5. Desmopressin induces decrease in platelet count in uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Thromb Haemost; 1986 Jun; 55(3):436. PubMed ID: 3750273
    [No Abstract]   [Full Text] [Related]  

  • 6. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
    Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
    Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia.
    Zeigler ZR; Megaludis A; Fraley DS
    Am J Hematol; 1992 Feb; 39(2):90-5. PubMed ID: 1550112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
    Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 12. Desmopressin and super platelets.
    Pecci A; Balduini CL
    Blood; 2014 Mar; 123(12):1779-80. PubMed ID: 24652962
    [No Abstract]   [Full Text] [Related]  

  • 13. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
    Wun T; Paglieroni TG; Lachant NA
    J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy.
    Ranucci M; Nano G; Pazzaglia A; Bianchi P; Casana R; Tealdi DG
    J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):851-4. PubMed ID: 18068065
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
    D'Angelo A; Capitanio A; Smith JB; Valsecchi C; Mannucci PM
    Thromb Haemost; 1983 Feb; 49(1):64-5. PubMed ID: 6687766
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet and plasma serotonin concentrations in glomerulonephritis, II.
    Parbtani A; Frampton G; Cameron JS
    Clin Nephrol; 1980 Sep; 14(3):112-23. PubMed ID: 7418277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced response of uraemic bleeding time to repeated doses of desmopressin.
    Canavese C; Salomone M; Pacitti A; Mangiarotti G; Calitri V
    Lancet; 1985 Apr; 1(8433):867-8. PubMed ID: 2858723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.